Enovis 

$41.6
14
+$0+0% 今天

统计数据

当日最高
41.6
当日最低
41.42
52周最高
65.36
52周最低
39.36
成交量
2
平均成交量
26
市值
-
市盈率
-
股息收益率
-
股息
-

即将到来

收益

6Nov预期
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
下一个
0.37
0.51
0.65
0.79
预期每股收益
0.62
实际每股收益
N/A

人们还关注

此列表基于关注0I1B.LSE的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。

关于

Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.
Show more...
首席执行官
Mr. Mitchell P. Rales
员工
16200
国家
United States
ISIN
US1940145022

上市公司